AIP
CRDF icon

Ameritas Investment Partners’s Cardiff Oncology CRDF Stock Holding History

Ameritas Investment Partners’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.2K Hold
5,678
– – ﹤0.01% 2889
2025
Q4 		$16K Hold
5,678
– – ﹤0.01% 2745
2025
Q3 		$11.7K Buy
5,678
+1,840
+48% +$5.08K ﹤0.01% 2905
2025
Q2 		$12.1K Hold
3,838
– – ﹤0.01% 2911
2025
Q1 		$12.1K Hold
3,838
– – ﹤0.01% 2758
2024
Q4 		$16.7K Hold
3,838
– – ﹤0.01% 2707
2024
Q3 		$10.2K Hold
3,838
– – ﹤0.01% 2909
2024
Q2 		$8.52K Buy
+3,838
New +$14.5K ﹤0.01% 2970
2022
Q2 		– Sell
-2,835
Closed -$7K – 3097
2022
Q1 		$7K Hold
2,835
– – ﹤0.01% 2888
2021
Q4 		$17K Hold
2,835
– – ﹤0.01% 2706
2021
Q3 		$19K Hold
2,835
– – ﹤0.01% 2724
2021
Q2 		$19K Buy
+2,835
New +$24K ﹤0.01% 2758
2017
Q2 		– Sell
-26
Closed -$2K – 3005
2017
Q1 		$2K Buy
+26
New +$3.53K ﹤0.01% 2918

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Ameritas Investment Partners's CRDF Position: Q1 2026 in Review

Ameritas Investment Partners held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 5,678 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Ameritas Investment Partners first reported a position in CRDF in Q1 2017 and has held it in 13 quarters since. The position peaked at $19K in Q3 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Ameritas Investment Partners held 5,678 shares of Cardiff Oncology worth $9.2K as of Q1 2026.
  • Ameritas Investment Partners left its Cardiff Oncology share count unchanged in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2889 holding.
  • Ameritas Investment Partners first reported a position in Cardiff Oncology in Q1 2017 and has held it in 13 quarters since.
  • Ameritas Investment Partners's Cardiff Oncology position peaked at $19K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.